Basal nitric oxide activity is an independent determinant of arteriolar structure in the human retinal circulation

Journal of Hypertension

Volumn 29, Issue 1, 2011, Pages 123-129

  Ritt, Martin ^a   Harazny, Joanna M ^a   Ott, Christian ^a   Raff, Ulrike ^a   Schneider, Markus P ^a   Michelson, Georg ^b   Schmieder, Roland E ^a  

^a Department of Nephrology and Hypertension ^*  (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

arterial remodeling; retina; vascular function

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE;

ADULT; ARTERIOLE; ARTICLE; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA CAPILLARY; VASODILATATION;

EID: 78650815241     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283406940     Document Type: Article

References (32)

1. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38:581-587.
2. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004; 17:1192-1200.
3. Izzard AS, Rizzoni D, Agabiti-Rosei E, Heagerty AM. Small artery structure and hypertension: adaptive changes and target organ damage.J Hypertens 2005; 23:247-250.
4. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 2001; 19:921-930.
5. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003; 108:2230-2235.
6. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, et al. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 2007; 25:1021-1026.
7. De Ciuceis C, Porteri E, Rizzoni D, Rizzardi N, Paiardi S, Boari GE, et al. Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertens 2007; 20:846-852.
8. Delaey C, Van De Voorde J. Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res 2000; 32:249-256.
9. Pournaras CJ, Rungger-Brändle E, Riva CE, Hardarson SH, Stefansson E. Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 2008; 27:284-330.
10. Delles C, Michelson G, Harazny J, Oehmer S, Hilgers KF, Schmieder RE. Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke 2004; 35:1289-1293.
11. Harazny JM, Ritt M, Baleanu D, Ott C, Heckmann J, Schlaich MP, et al. Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension 2007; 50:623-629.
12. Dorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE, Schmetterer L. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol 2003; 285:H631-H636.
13. Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimokawa H, Sueishi K, Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension 1995; 26:957-962.
14. Ito A, Egashira K, Kadokami T, Fukumoto Y, Takayanagi T, Nakaike R, et al. Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyperreactivity to serotonin in pigs. Circulation 1995; 92:2636-2644.
15. Chillon JM, Ghoneim S, Baumbach GL. Effects of chronic nitric oxide synthase inhibition on cerebral arterioles in rats. Hypertension 1997; 30:1097-1104.
16. Baumbach GL, Sigmund CD, Faraci FM. Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase. Circ Res 2004; 95:822-829.
17. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Tiberio G, et al. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension 1998; 31:335-341.
18. Rizzoni D, Agabiti-Rosei E. Endothelial factors and microvascular hypertensive disease. J Cardiovasc Pharmacol 2001; 38:S15-S18.
19. Arribas SM, Gonzalez C, Graham D, Dominiczak AF, McGrath JC. Cellular changes induced by chronic nitric oxide inhibition in intact rat basilar arteries revealed by confocal microscopy. J Hypertens 1997; 15:1685-1693.
20. Vita JA, Holbrook M, Palmisano J, Shenouda SM, Chung WB, Hamburg NM, et al. Flow-induced arterial remodeling relates to endothelial function in the human forearm. Circulation 2008; 117:3126-3133.
21. Hashimoto M, Eto M, Akishita M, Kozaki K, Ako J, Iijima K, et al. Correlation between flow-mediated vasodilatation of the brachial artery and intima-media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol 1999; 19:2795-2800.
22. Ghiadoni L, Taddei S, Virdis A, Sudano I, Di Legge V, Meola M, et al. Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension 1998; 32:25-32.
23. Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, Raitakari OT. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation 2004; 110:2918-2923.
24. Campuzano R, Moya JL, Garcia-Lledo A, Tomas JP, Ruiz S, Megias A, et al. Endothelial dysfunction, intima-media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis. J Hypertens 2006; 24:1581-1588.
25. Thalhammer C, Balzuweit B, Busjahn A, Walter C, Luft FC, Haller H. Endothelial cell dysfunction and arterial wall hypertrophy are associated with disturbed carbohydrate metabolism in patients at risk for cardiovascular disease. Arterioscler Thromb Vasc Biol 1999; 19:1173-1179.
26. Yan RT, Anderson TJ, Charbonneau F, Title L, Verma S, Lonn E. Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol 2005; 45:1980-1986.
27. Lind L. Left ventricular mass is related to endothelium-dependent vasodilation in the forearm, but not in the brachial artery, in elderly subjects: the Prospective Investigation of the Vasculature in Uppsala Seniors study. J Hum Hypertens 2008; 22:767-773.
28. Olsen MH, Wachtell K, Hermann KL, Bella JN, Dige-Petersen H, Rokkedal J, Ibsen H. Left ventricular hypertrophy is associated with reduced vasodilatory capacity in the brachial artery in patients with longstanding hypertension. A LIFE substudy. Blood Press 2002; 11:285-292.
29. Muiesan ML, Salvetti M, Monteduro C, Corbellini C, Guelfi D, Rizzoni D, et al. Flow-mediated dilatation of the brachial artery and left ventricular geometry in hypertensive patients. J Hypertens 2001; 19:641-647.
30. Ott C, Schlaich MP, Harazny J, Schmidt BM, Michelson G, Schmieder RE. Effects of angiotensin II type 1-receptor blockade on retinal endothelial function. J Hypertens 2008; 26:516-522.
31. Mandecka A, Dawczynski J, Blum M, Müller N, Kloos C, Wolf G, et al. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 2007; 30:3048-3052.
32. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005; 308:1583-1587.